TRAVERE THERAPEUTICS INC

Ticker: TVTX CUSIP: 89422G107 Class: Common Stock

ORBIMED ADVISORS LLC's Holding History (CIK: 0001055951)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023

Shares 2,118,100 Value ($000) $32,534 Avg Close $18.19 Range $14.51 - $23.18

Q1 2023

Shares 1,744,300 Value ($000) $39,229 Avg Close $21.26 Range $17.82 - $23.18

Q4 2022

Shares 1,253,130 Value ($000) $26,353 Avg Close $21.19 Range $17.97 - $26.55

Q3 2022

Shares 1,253,130 Value ($000) $30,877 Avg Close $25.84 Range $22.00 - $29.14

Q2 2022

Shares 772,200 Value ($000) $18,710 Avg Close $25.15 Range $20.80 - $30.35

Q1 2021

Shares 528,100 Value ($000) $13,187 Avg Close $27.63 Range $22.39 - $33.09

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2023	2,118,100	$32,534	$18.19	$14.51 - $23.18
Q1 2023	1,744,300	$39,229	$21.26	$17.82 - $23.18
Q4 2022	1,253,130	$26,353	$21.19	$17.97 - $26.55
Q3 2022	1,253,130	$30,877	$25.84	$22.00 - $29.14
Q2 2022	772,200	$18,710	$25.15	$20.80 - $30.35
Q1 2021	528,100	$13,187	$27.63	$22.39 - $33.09